Bio-Rad Laboratories Inc. - Ordinary Shares - Class A

NYSE:BIO  
602.09
-0.88 (-0.15%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)17.93B
Current PE4.38
Forward PE 48.71
2yr Forward PE 48.67
See more stats
Estimates Current Quarter
Revenue$646.13 Million
Adjusted EPS$2.66
See more estimates
10-Day MA$590.64
50-Day MA$603.98
200-Day MA$577.19
See more pivots

Bio-Rad Laboratories Inc. - Ordinary Shares - Class A Stock, NYSE:BIO

1000 Alfred Nobel Drive, Hercules, California 94547
United States of America
Phone: +1.510.724.7000
Number of Employees: 8000

Description

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Sciences and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.